Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease
NCT02596997 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2022-03-14
Summary
Provide patients with serious AdV infection or disease access to treatment with BCV.
Conditions
- Adenovirus
Interventions
- DRUG
-
Brincidofovir
Up to 100mg Brincidofovir twice weekly, not to exceed a total dose of 200mg each week
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
CMX001 in Post-transplant Patients With BK Virus Viruria
NCT00793598 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS
NCT00000693 ·Status: COMPLETED ·Phase: NA
-
A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
NCT00000698 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
NCT00000726 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease
NCT02439970 ·Status: TERMINATED ·Phase: PHASE3
-
Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
NCT00000142 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
NCT00017784 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS
NCT00001061 ·Status: COMPLETED ·Phase: PHASE2
-
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
NCT00002024 ·Status: COMPLETED ·Phase: NA
-
Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
NCT00002025 ·Status: COMPLETED ·Phase: NA
-
A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure
NCT00000691 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002437 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients
NCT01769170 ·Status: COMPLETED ·Phase: PHASE3
-
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
NCT01611974 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
NCT00000673 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis
NCT00002187 ·Status: COMPLETED ·Phase: NA
-
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
NCT00002070 ·Status: COMPLETED ·Phase: PHASE3
-
HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol
NCT00000799 ·Status: COMPLETED ·Phase: NA
-
Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients
NCT00497796 ·Status: COMPLETED ·Phase: PHASE3
-
Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
NCT00000136 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
NCT00002377 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS
NCT00002142 ·Status: COMPLETED ·Phase: NA
-
The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS
NCT00000989 ·Status: COMPLETED ·Phase: NA